NuCana (FRA:N040) GF Score: 25/100 (As of Jul. 08, 2026) — 17% Below Median


FRA:N040 NuCana PLC FRA:N040
25 GF Score
Price €3.20
! 2 Warning Signs
View Full Analysis

What is NuCana GF Score?

NuCana FRA:N040 25 GF Score is 25 as of Jul. 08, 2026, which is 17% below its 10-year median of 30.00. GuruFocus rates FRA:N040 with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

NuCana has the GF Score of 25, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 7/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes NuCana might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

NuCana  (FRA:N040) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

NuCana GF Score Related Terms

FRA:N040 vs LABT, APM, SNGX: GF Score Comparison

For the Biotechnology subindustry, NuCana's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NuCana GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NuCana's GF Score distribution charts can be found below:

* The bar in red indicates where NuCana's GF Score falls into.


FRA:N040
25GF Score
NuCana PLC FRA:N040
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 25 mean?
NuCana (FRA:N040) has a GF Score of 25 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on NuCana and its competitors. This is 17% below median its historical median of 30.00. Over the past decade, NuCana's GF Score has ranged from 11.00 to 41.00.
Is NuCana's GF Score too high?
NuCana's current GF Score of 25 is 17% below median its 10-year median of 30.00. Over the past 10 years, this metric has ranged from a low of 11.00 to a high of 41.00. Overall, NuCana has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does NuCana's GF Score compare to LABT and APM?
NuCana's GF Score of 25 can be compared against companies in the Biotechnology industry. Historically, NuCana's own GF Score has ranged from 11.00 to 41.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on NuCana and its competitors. NuCana's current GF Score is 25, which is 17% below median its own 10-year median of 30.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuCana stock overvalued right now?
NuCana (FRA:N040) has a current GF Score of 25. The current GF Score is 25, which is 17% below median its 10-year median of 30.00. NuCana's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For NuCana (FRA:N040), the current GF Score is 25 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NuCana Business Description

Other Exchanges NCNA:USA
Address 3 Lochside Way, Edinburgh, GBR, EH12 9DT
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
25GF Score

Get the complete analysis for FRA:N040

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.20
Price